Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians.
Saved in:
| Title: | Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians. |
|---|---|
| Authors: | Singh N; University of Washington, Seattle., Grivas P; University of Washington and Fred Hutchinson Cancer Center, Seattle., Makris UE; University of Texas Southwestern Medical Center, Dallas., Suarez-Almazor ME; The University of Texas MD Anderson Cancer Center, Houston., O'Hare AM; Department of Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle., Barton JL; Oregon Health and Science University and Department of Veterans Affairs Portland Health Care System, Portland. |
| Source: | ACR open rheumatology [ACR Open Rheumatol] 2023 Jun; Vol. 5 (6), pp. 305-307. Date of Electronic Publication: 2023 May 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101740025 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-5745 (Electronic) Linking ISSN: 25785745 NLM ISO Abbreviation: ACR Open Rheumatol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
